Abnormal expression of GABAA receptor subunits and hypomotility upon loss of gabra1 in zebrafish

ABSTRACT We used whole-exome sequencing (WES) to determine the genetic etiology of a patient with a multi-system disorder characterized by a seizure phenotype. WES identified a heterozygous de novo missense mutation in the GABRA1 gene (c.875C>T). GABRA1 encodes the alpha subunit of the gamma-aminobutyric acid receptor A (GABAAR). The GABAAR is a ligand gated ion channel that mediates the fast inhibitory signals of the nervous system, and mutations in the subunits that compose the GABAAR have been previously associated with human disease. To understand the mechanisms by which GABRA1 regulates brain development, we developed a zebrafish model of gabra1 deficiency. gabra1 expression is restricted to the nervous system and behavioral analysis of morpholino injected larvae suggests that the knockdown of gabra1 results in hypoactivity and defects in the expression of other subunits of the GABAAR. Expression of the human GABRA1 protein in morphants partially restored the hypomotility phenotype. In contrast, the expression of the c.875C>T variant did not restore these behavioral deficits. Collectively, these results represent a functional approach to understand the mechanisms by which loss-of-function alleles cause disease. Summary: By coupling human medical genetics and in vivo functional analysis we show that GABRA1 regulates motility and the expression of specific subunits of the GABAA receptor during zebrafish development.

[1]  J. Belmont,et al.  Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases , 2019, Journal of Medical Genetics.

[2]  Emily G. Kelley,et al.  Cases from the Undiagnosed Diseases Network: The continued value of counseling skills in a new genomic era , 2019, Journal of genetic counseling.

[3]  P. Drapeau,et al.  γ‐Aminobutyric acid receptor alpha 1 subunit loss of function causes genetic generalized epilepsy by impairing inhibitory network neurodevelopment , 2018, Epilepsia.

[4]  Shanshan Zhang,et al.  Gastrodin Suppresses Pentylenetetrazole-Induced Seizures Progression by Modulating Oxidative Stress in Zebrafish , 2018, Neurochemical Research.

[5]  G. Downes,et al.  Expression of the eight GABAA receptor α subunits in the developing zebrafish central nervous system , 2018, bioRxiv.

[6]  S. Kingsmore,et al.  Rapid whole-genome sequencing identifies a novel GABRA1 variant associated with West syndrome , 2017, Cold Spring Harbor molecular case studies.

[7]  Michael F. Wangler,et al.  Model Organisms Facilitate Rare Disease Diagnosis and Therapeutic Research , 2017, Genetics.

[8]  U. Stephani,et al.  Gene expression analysis in untreated absence epilepsy demonstrates an inconsistent pattern , 2017, Epilepsy Research.

[9]  Xiuyun Liu,et al.  Anxiety-related behavioral responses of pentylenetetrazole-treated zebrafish larvae to light-dark transitions , 2016, Pharmacology Biochemistry and Behavior.

[10]  Naomichi Matsumoto,et al.  De novo GABRA1 mutations in Ohtahara and West syndromes , 2016, Epilepsia.

[11]  F. Arain,et al.  The developmental evolution of the seizure phenotype and cortical inhibition in mouse models of juvenile myoclonic epilepsy , 2015, Neurobiology of Disease.

[12]  B. Fernandez,et al.  Utility of whole‐exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care , 2015, Clinical genetics.

[13]  M. Tétreault,et al.  Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities , 2015, Expert review of molecular diagnostics.

[14]  R. Emeson,et al.  Altered intrathalamic GABAA neurotransmission in a mouse model of a human genetic absence epilepsy syndrome , 2015, Neurobiology of Disease.

[15]  E. Hoffman,et al.  Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease , 2014 .

[16]  Krissi Danielsson,et al.  Next-generation sequencing applied to rare diseases genomics , 2014, Expert review of molecular diagnostics.

[17]  R. Wilson,et al.  The Next-Generation Sequencing Revolution and Its Impact on Genomics , 2013, Cell.

[18]  K. Boycott,et al.  Rare-disease genetics in the era of next-generation sequencing: discovery to translation , 2013, Nature Reviews Genetics.

[19]  Michael R. Johnson,et al.  De novo mutations in the classic epileptic encephalopathies , 2013, Nature.

[20]  Peter A. M. de Witte,et al.  Validation of the Zebrafish Pentylenetetrazol Seizure Model: Locomotor versus Electrographic Responses to Antiepileptic Drugs , 2013, PloS one.

[21]  E. Sigel,et al.  Structure, Function, and Modulation of GABAA Receptors* , 2012, The Journal of Biological Chemistry.

[22]  K. Boyd,et al.  Decreased viability and absence‐like epilepsy in mice lacking or deficient in the GABAA receptor α1 subunit , 2012, Epilepsia.

[23]  Christian Gilissen,et al.  Disease gene identification strategies for exome sequencing , 2012, European Journal of Human Genetics.

[24]  C. C. Hernandez,et al.  The GABRA6 mutation, R46W, associated with childhood absence epilepsy, alters α6β2γ2 and α6β2δ GABAA receptor channel gating and expression , 2011, The Journal of physiology.

[25]  Christian Gilissen,et al.  Unlocking Mendelian disease using exome sequencing , 2011, Genome Biology.

[26]  L. Carmant,et al.  Novel α1 and γ2 GABAA receptor subunit mutations in families with idiopathic generalized epilepsy , 2011, The European journal of neuroscience.

[27]  A. Nekrutenko,et al.  Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences , 2010, Genome Biology.

[28]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[29]  Holger Lerche,et al.  A mutation in the GABAA receptor α1‐subunit is associated with absence epilepsy , 2006 .

[30]  Michael R. Taylor,et al.  Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression , 2005, Neuroscience.

[31]  B. Paw,et al.  Zebrafish: a genetic model for vertebrate organogenesis and human disorders. , 2003, Frontiers in bioscience : a journal and virtual library.

[32]  Wei-Yang Lu,et al.  Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy , 2002, Nature Genetics.

[33]  D. Covey,et al.  Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action. , 2001, The Journal of pharmacology and experimental therapeutics.

[34]  M. Fanselow,et al.  Mice Lacking the β3 Subunit of the GABAA Receptor Have the Epilepsy Phenotype and Many of the Behavioral Characteristics of Angelman Syndrome , 1998, The Journal of Neuroscience.

[35]  Danielle Nolan,et al.  Genetics of epilepsy. , 2018, Handbook of clinical neurology.

[36]  R. Macdonald,et al.  The Genetic Epilepsies , 2015 .

[37]  S. Hirose Mutant GABA(A) receptor subunits in genetic (idiopathic) epilepsy. , 2014, Progress in brain research.

[38]  Claude-Alain H. Roten,et al.  Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..

[39]  B. Thisse,et al.  High-resolution in situ hybridization to whole-mount zebrafish embryos , 2007, Nature Protocols.